STOCK TITAN

Vivid Seats plans to swap about $273M in debt for stock

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Vivid Seats Inc. (SEAT) entered into a Transaction Support Agreement for a proposed recapitalization with lenders holding a substantial majority of its term loans. It would exchange approximately $273 million of secured debt for approximately 45.8 million new Class A shares; lenders would hold approximately 80% of post-transaction common equity, while existing shareholders would retain approximately 11.5 million shares (approximately 20%). The plan includes $66 million of new first lien, first out term loans, including $6 million of fees paid-in-kind, and extends term loan maturities to January 2032 from February 2029.

Vivid Seats says the transaction would reduce net debt by approximately $232 million. Pro forma estimates are total debt of $180 million versus $387 million, net debt of approximately $110 million versus $342 million, and net leverage of approximately 2.97x versus approximately 9.24x, based on September 30, 2026 levels. Estimates assume a January 2027 closing and 100% lender participation; net leverage uses the midpoint of 2026 adjusted EBITDA guidance. Closing is expected in the first quarter of 2027, subject to customary conditions, including at least 99% participation by existing term-loan holders, subject to agreed reduction or waiver, definitive documentation and fees.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate point. Forward-looking: it has not happened yet and may not happen.If completed, the proposed recapitalization would reduce net debt by approximately $232 million. 16× market cap

Negative

  • Moderate point. Forward-looking: it has not happened yet and may not happen.If completed, the proposed issuance would give lenders approximately 80% of post-transaction common equity.

Filing Explained

The recapitalization remains unclosed under a binding support pact that expires January 31, 2027, unless specified extension conditions apply.

The signed support agreement commits the company parties and consenting lenders to facilitate the recapitalization, but the exchange remains contingent on closing. The company parties also agreed to pursue definitive documents, follow interim operating covenants, and not pursue an alternative transaction subject to a fiduciary-duty exception; lenders agreed to support and not impede the deal and generally may transfer loans only to parties bound by the agreement. Either the company or required lenders may terminate the agreement after specified events, and it automatically ends if closing has not occurred by January 31, 2027, unless extended in specified circumstances to March 31, 2027.

Separately, the company entered retention agreements with four named executive officers: Lawrence Fey, Joseph Thomas and Stefano Langenbacher each have a $771,000 payment, and Edward Pickus has a $578,000 payment, with half of each payable immediately and half on November 18, 2027. If an executive leaves before then under specified circumstances, the unpaid installment is forfeited, and a qualifying termination can also require repayment of a pro rata, after-tax portion of the first installment, while a change in control makes the second installment immediately payable and ends that repayment obligation.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Net debt reduction Approximately $232 million Stated effect of the proposed recapitalization upon completion
Secured debt exchanged Approximately $273 million To be exchanged for approximately 45.8 million new Class A shares
New Class A shares Approximately 45.8 million shares To be issued to consenting lenders upon consummation
Post-transaction common equity ownership Lenders: approximately 80%; existing shareholders: approximately 20% Following completion of the proposed transaction
New first lien, first out term loans $66 million Inclusive of $6 million of fees paid-in-kind
Pro forma total debt $180 million Versus $387 million at September 30, 2026; estimate assumes a January 2027 closing and 100% lender participation
Pro forma net debt Approximately $110 million Versus $342 million at September 30, 2026; estimate assumes a January 2027 closing and 100% lender participation
Pro forma net leverage Approximately 2.97x Versus approximately 9.24x at September 30, 2026; based on the midpoint of 2026 adjusted EBITDA guidance
Transaction Support Agreement financial
"entered into a Transaction Support Agreement"
A transaction support agreement is a contract among the parties involved in a pending deal that spells out who must do what, who bears which risks, and how any problems discovered before or after closing will be handled. Think of it as a moving checklist and shared rulebook that helps the deal finish smoothly. Investors care because its terms affect the likelihood and timing of closing, potential costs or liabilities after the deal, and the value or dilution of their holdings.
New First Out Term Loans financial
"Fronting Lender for the New First Out Term Loans"
paid-in-kind financial
"fees paid-in-kind"
Paid-in-kind describes an arrangement where a borrower pays interest or returns not with cash but by issuing more of the same security (extra bonds or shares) or by increasing the loan balance. For investors this matters because it conserves the issuer’s cash but can dilute ownership or increase debt over time, changing expected cash payments, risk and the real value of an investment much like being paid with an IOU instead of cash.
Minimum Participation Condition technical
"the Minimum Participation Condition"
net leverage financial
"net leverage is based on the midpoint of 2026 adjusted EBITDA guidance"
Net leverage measures how many years it would take for a company to pay off its outstanding debt using its annual operating cash flow, after subtracting cash on hand from total debt. Think of it like a household’s mortgage balance minus savings divided by yearly income; a lower number means the company is in a safer position to handle debt, while a higher number signals greater financial risk and potential pressure on profits or growth.
fiduciary out technical
"the exercise of the fiduciary out described above"
A fiduciary out is a clause in a merger or sale agreement that lets a company’s board abandon a planned deal if the board honestly believes a different offer or action would better protect shareholders’ interests. It matters to investors because it can increase the chance of a higher bid or a better outcome, but it also reduces deal certainty and can trigger negotiations over compensation or legal challenges. Think of it as an agent’s right to refuse a sale if a better deal appears.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What net debt reduction does Vivid Seats (SEAT) expect from the recapitalization?

If completed, the recapitalization is expected to reduce net debt by approximately $232 million and includes $66 million of new first lien, first out term loans, inclusive of $6 million of fees paid-in-kind.

How much Vivid Seats (SEAT) equity would go to lenders?

Approximately 45.8 million new Class A shares would be exchanged for approximately $273 million of secured debt. Lenders would hold approximately 80% of common equity after completion; existing shareholders would retain approximately 11.5 million shares, or approximately 20%.

What conditions must Vivid Seats (SEAT) meet to close the recapitalization?

Closing requires participation by holders of at least 99% of the existing term loans, subject to reduction or waiver agreed by Vivid Seats and certain consenting lenders, as well as definitive transaction documentation and payment of applicable fees and expenses. Closing is expected in the first quarter of 2027.

What retention payments did Vivid Seats (SEAT) agree to for its named executive officers?

Named executive officers Lawrence Fey (Chief Executive Officer), Joseph Thomas (Chief Financial Officer), and Stefano Langenbacher each receive $771,000; named executive officer Edward Pickus receives $578,000. Half of each payment is payable immediately and half on November 18, 2027. A change in control before then makes the second installment immediately payable and lapses repayment of the first installment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 18, 2026

 

Vivid Seats Inc.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other 

jurisdiction of incorporation)

001-40926

(Commission File Number)

86-3355184

(IRS Employer

Identification No.)

     

24 East Washington Street, Suite 900

Chicago, Illinois

(Address of principal executive offices)

60602

(Zip Code)

       

Registrant’s telephone number, including area code: (312) 291-9966

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: 

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A common stock, par value $0.0001 per share   SEAT   The Nasdaq Stock Market LLC
Warrants to purchase Class A common stock   SEATW   The Nasdaq Stock Market LLC*

 

* On October 16, 2026, The Nasdaq Stock Market LLC filed a Form 25 with the Securities and Exchange Commission (the “SEC”) to (i) delist these warrants from the Nasdaq Global Select Market, which delisting became effective on October 26, 2026, and (ii) remove these warrants from registration under Section 12(b) of the Securities Exchange Act of 1934, which deregistration will become effective 90 days, or such shorter period as the SEC may determine, after such filing.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 1.01 Entry into a Material Definitive Agreement

 

On November 19, 2026, Vivid Seats Inc. (the “Company”), Hoya Intermediate, LLC (“Holdings”), Hoya Midco, LLC (the “Borrower”), and certain other subsidiaries of the Company (collectively, the “Company Parties”) entered into a Transaction Support Agreement (together with the exhibits and schedules thereto, including the term sheet attached as Exhibit A thereto, the “TSA”) with (i) certain lenders (the “Consenting Lenders”) holding a substantial majority of the aggregate outstanding principal amount of the term loans (the “Existing Term Loans”) under the First Lien Credit Agreement, dated June 30, 2017 (as amended, restated, supplemented, or otherwise modified from time to time, the “Existing Term Loan Credit Agreement”), among Holdings, the Borrower, the lenders party thereto, and Wilmington Savings Fund Society, FSB (as successor-in-interest to Barclays Bank PLC), as administrative agent and collateral agent, and (ii) Jefferies Capital Services, LLC, as fronting lender (the “Fronting Lender”) for the New First Out Term Loans (as defined below).

 

The TSA sets forth the terms on which the parties have agreed to support and implement a comprehensive recapitalization of the Company’s capital structure (collectively, the “Transactions”). The Transactions include, among others:

 

• Term Loan Exchange. Each Consenting Lender will exchange its Existing Term Loans for (i) $2,944.75 in aggregate principal amount of new first lien, second out term loans (the “Exchanged Second Out Term Loans”) for each $10,000.00 of principal amount of Existing Term Loans held by such Consenting Lender immediately prior to the closing date of the Transactions (the “Closing Date”) and (ii) its pro rata portion of newly issued shares of the Company’s Class A common stock (the “New Common Equity”) representing, in the aggregate, 80.0% of the Company’s Class A common stock immediately following consummation of the Transactions (the “Term Loan Exchange”). No Consenting Lender will hold more than 19.99% of the Company’s Class A common stock immediately following consummation of the Transactions. Existing holders of the Company’s Class A common stock will retain, in the aggregate, 20.0% of the Company’s Class A common stock immediately following consummation of the Transactions.

 

• New Money Financing. The Borrower will receive $66.0 million of new first lien, first out term loans (inclusive of $6.0 million of fees paid-in-kind) (the “New First Out Term Loans”), which will be offered on a pro rata basis to holders of Existing Term Loans that become Consenting Lenders on or prior to the date that is seven days after the TSA is posted to holders of Existing Term Loans (or such later date as may be agreed by the Company and certain of the Backstop Parties (as defined below)). The New First Out Term Loans will be initially funded by the Fronting Lender and have been fully backstopped, severally and not jointly, by certain Consenting Lenders (the “Backstop Parties”).

 

• Other Closing Terms. The Transactions also contemplate, among other things, (i) the entry into a new credit agreement governing the New First Out Term Loans and the Exchanged Second Out Term Loans, (ii) an amendment to the Existing Term Loan Credit Agreement (the “Closing Amendment”), (iii) the repayment of the Company Parties’ existing revolving credit facility and intercompany senior secured credit facility, (iv) the reconstitution of the Company’s board of directors, (v) the adoption of a management incentive plan, (vi) the entry into a registration rights agreement for the New Common Equity, and (vii) customary mutual releases, in each case on terms to be set forth in definitive documentation entered into on or prior to the Closing Date.

 

Under the TSA, the Company Parties have agreed, among other things, to support and take all commercially reasonable actions necessary to facilitate the implementation and consummation of the Transactions, to negotiate in good faith and execute the definitive documentation for the Transactions, to not solicit or pursue any alternative transaction (subject to the right of the governing body of each Company Party to take actions consistent with its fiduciary duties), and, between the date of the TSA and the Closing Date, to comply with customary interim operating covenants. 

 

Under the TSA, each Consenting Lender has agreed, severally and not jointly, among other things, to support and take all commercially reasonable actions to facilitate the implementation and consummation of the Transactions, to provide all consents required for the Transactions, including the Closing Amendment, to not object to or impede the Transactions or support any alternative restructuring of the Existing Term Loans, and to not transfer its Existing Term Loans except to a transferee that is or agrees to become bound by the TSA.

 

The consummation of the Transactions is subject to customary conditions, including participation by holders of at least 99% of the Existing Term Loans, subject to reduction or waiver if agreed by the Company and certain of the Consenting Lenders (the “Minimum Participation Condition”), the execution of definitive documentation, and the payment of fees. The TSA may be terminated by the Company or the required Consenting Lenders upon the occurrence of certain specified events, including uncured breaches, failure to meet specified milestones, and the exercise of the fiduciary out described above. The TSA will terminate automatically if the Closing Date has not occurred by January 31, 2027 (extendable in specific circumstances to March 31, 2027).

 

The TSA contains customary representations, warranties, and covenants of the parties, which were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties, and may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures. Investors should not rely on them as characterizations of the actual state of facts. There can be no assurance that the Transactions will be consummated on the terms described herein or at all.

 

The foregoing description of the TSA and the Transactions does not purport to be complete and is qualified in its entirety by reference to the full text of the TSA, including the term sheet attached as Exhibit A thereto, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

Item 3.02 Unregistered Sales of Equity Securities

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02. Upon consummation of the Term Loan Exchange, the Company will issue the New Common Equity (approximately 45.8 million shares of Class A common stock) to the Consenting Lenders in exchange for a portion of Existing Term Loans. Such issuance will be made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On November 18, 2026, the Company entered into retention agreements with certain key employees, including each of the Company’s named executive officers (“NEOs”). The retention agreements provide for retention payments to Lawrence Fey, Joseph Thomas, Stefano Langenbacher, and Edward Pickus in the aggregate amount of $771,000, $771,000, $771,000, and $578,000, respectively. Fifty percent of each retention payment is payable immediately, and the remaining fifty percent is payable on November 18, 2027.

 

If an NEO’s employment is terminated prior to November 18, 2027 by the Company for Cause (as defined in the NEO’s employment agreement) or by the NEO without Good Reason (as defined in the NEO’s employment agreement), then the NEO will be required to repay a pro rata, after-tax portion of the first installment of the retention payment and will forfeit the right to the second installment. If an NEO’s employment is terminated for any other reason prior to November 18, 2027, the repayment obligation with respect to the first installment of the retention payment will lapse, but the NEO will not be entitled to receive the second installment. If a Change in Control (as defined in the Company’s 2021 Incentive Award Plan, as amended) occurs prior to November 18, 2027, the repayment obligation with respect to the first installment of the retention payment will lapse and the second installment will become immediately payable. 

 

Item 7.01 Regulation FD Disclosure

 

On November 19, 2026, the Company issued a press release announcing its entry into the TSA. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

In connection with its discussions regarding the Transactions, the Company entered into confidentiality agreements with certain holders of Existing Term Loans pursuant to which it agreed to publicly disclose certain information provided to such holders (the “Cleansing Material”) upon the occurrence of certain events. The Cleansing Material is furnished as Exhibit 99.2 to this Current Report on Form 8-K. The Cleansing Material was prepared as of earlier dates using then-available information solely to facilitate such discussions and speaks only as of such dates. The Cleansing Material was not prepared with a view toward public disclosure and should not be relied upon to make an investment decision with respect to the Company. The Cleansing Material should not be regarded or relied upon as an indication that the Company or any third party considers the Cleansing Material to be a reliable prediction of future events. The Cleansing Material includes certain values that were prepared for illustrative purposes only and are not the result of, and do not necessarily represent, actual valuations, estimates, forecasts, or projections of the Company or any third party and should not be relied upon as such. Neither the Company nor any third party has made or makes any representation to any person regarding the accuracy of the Cleansing Material or undertakes any obligation to publicly update or revise the Cleansing Material to reflect circumstances existing after the date on which it was prepared or conveyed or to reflect the occurrence of future events, even in the event that any or all of the assumptions underlying the Cleansing Material are shown to be incorrect.

 

The information set forth under this Item 7.01, including Exhibits 99.1 and 99.2 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Forward-Looking Statements

 

This report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act regarding future events and trends and the future results of the Company and its subsidiaries. Words such as “anticipate,” “believe,” “can,” “continue,” “could,” “design,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “plan,” “project,” “propose,” “seek,” “should,” “target,” “will” and “would,” as well as similar expressions that predict or indicate future events and trends or do not relate to historical matters, are intended to identify such forward-looking statements. The Company has based these forward-looking statements largely on its current expectations, estimates, forecasts, and projections about future events and financial trends that it believes may affect its business, financial condition, and results of operations. While the Company believes such information forms a reasonable basis for such statements, such information may be limited or incomplete, and the Company’s statements should not be read to indicate that it has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. Forward-looking statements are not guarantees of future performance, conditions, or results, and are subject to risks, uncertainties, and assumptions that can be difficult to predict and/or are outside of the Company’s control. Therefore, actual results may differ materially from those contemplated by any forward-looking statements. Important factors that could cause or contribute to such differences include, but are not limited to: the ability of the parties to consummate the Transactions on the terms or timeline proposed, or at all, including the satisfaction of the Minimum Participation Condition and other closing conditions; the possibility that the TSA is terminated prior to consummation of the Transactions; and other factors discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as well as in the Company’s press releases and other filings with the Securities and Exchange Commission (the “SEC”). You should not place undue reliance on forward-looking statements, which speak only as of the date of this report (or, in the case of statements incorporated by reference herein, as of the date of the incorporated statement). Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements contained in this report, whether as a result of new information, future events, or otherwise.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.   Description
10.1*   Transaction Support Agreement, dated as of November 19, 2026, by and among Vivid Seats Inc., the other Company Parties party thereto, the Consenting Lenders party thereto, and Jefferies Capital Services, LLC, as Fronting Lender
99.1   Press release issued by Vivid Seats Inc., dated November 19, 2026
99.2   Cleansing Material
104   Cover Page Interactive Data File (embedded within the Inline XBRL Document)

 

*Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K, and certain identified information has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish a copy of any omitted schedule or exhibit to the SEC upon request. 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

 

  Vivid Seats Inc.
   
Date: November 19, 2026 By: /s/ Joseph Thomas
    Joseph Thomas
    Chief Financial Officer

 




Exhibit 99.1

 

FOR IMMEDIATE RELEASE

 

Vivid Seats Enters Into Transaction Support Agreement for Comprehensive Recapitalization

 

Transaction Reduces Net Debt by $232 Million, Provides $66 Million of New First Lien, First Out Term Loans1, and Extends Term Loan Maturities to 2032

 

CHICAGO, November 19, 2026 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (Nasdaq: SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced that it has entered into a Transaction Support Agreement (the “TSA”) with an ad hoc group comprising a substantial majority of its term loan lenders to implement a comprehensive recapitalization.

 

The transaction represents a significant deleveraging of Vivid Seats’ balance sheet, reducing net debt by approximately $232 million while providing $66 million of new first lien, first out term loans (inclusive of $6 million of fees paid-in-kind) and extending remaining term loan maturities to 2032. Together, these measures enhance liquidity and financial flexibility and position Vivid Seats to execute on its long-term strategic objectives.

 

“We are pleased to have reached this agreement, which provides a durable capital structure that will support long-term equity value creation as we continue executing against our strategic objectives,” said Lawrence Fey, Chief Executive Officer of Vivid Seats. “We have leading technology, proprietary data, a compelling value proposition, and an exciting product roadmap. With our new capital structure, we can deliver the most rewarding ticket-buying experience for fans while creating value for our stakeholders.”

 

Transaction Details

 

The table below summarizes Vivid Seats’ current and pro forma capital structure following completion of the transaction.2

 

  9/30/2026 Pro Forma
Total Debt $387mm $180mm
Net Debt $342mm ~$110mm
Net Leverage ~9.24x ~2.97x
Term Loan Maturity
Feb. 2029 Jan. 2032

 

Approximately $273 million of secured debt will be exchanged for approximately 45.8 million newly issued shares of Class A common stock (~80% of the common equity following completion of the transaction). Existing shareholders will continue to hold approximately 11.5 million currently outstanding shares of Class A common stock (~20% of the common equity following completion of the transaction).

 

 

1 Inclusive of $6 million of fees paid-in-kind. 

2 Pro forma figures based on management’s estimate of net debt and cash assuming a closing date in January 2027 and assuming 100% lender participation; net leverage is based on the midpoint of 2026 adjusted EBITDA guidance. 

1

The transaction is expected to close in the first quarter of 2027, subject to the satisfaction or waiver of certain customary conditions set forth in the TSA, including the execution of definitive transaction documentation and the payment of applicable transaction fees and expenses.

 

For more information about the transaction, see the Current Report on Form 8-K filed today by Vivid Seats with the Securities and Exchange Commission.

 

Advisors

 

Latham & Watkins LLP is serving as legal advisor, Moelis & Company LLC is serving as investment banker, and FTI Consulting is serving as financial and communications advisor to Vivid Seats in connection with the transaction. Gibson, Dunn & Crutcher LLP is serving as legal advisor and Centerview Partners LLC is serving as investment banker to the ad hoc group of term loan lenders.

 

About Vivid Seats

 

Founded in 2001, Vivid Seats (Nasdaq: SEAT) is a leading online ticket marketplace connecting fans to the live events, artists, and teams they love. Vivid Seats is committed to delivering the most rewarding ticket-buying experience for fans through competitive everyday pricing backed by its Lowest Price Guarantee, an industry-leading rewards program, and award-winning customer service. The Chicago-based company offers one of the widest selections of live events across North America, powered by proprietary technology that makes discovering and buying tickets simple, affordable, and reliable. Learn more by downloading the Vivid Seats app or visiting vividseats.com.

 

Forward-Looking Statements:

 

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “can,” “continue,” “could,” “design,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “likely,” “may,” “plan,” “project,” “propose,” “seek,” “should,” “target,” “will,” and “would,” as well as similar expressions that predict or indicate future events or do not relate to historical matters, are intended to identify such forward-looking statements. Such forward-looking statements may relate to, without limitation: the expected timing of closing of the transaction; the anticipated benefits of the transaction; and Vivid Seats’ pro forma capital structure following completion of the transaction. Forward-looking statements are not guarantees of future performance, conditions, or results, and are subject to risks and uncertainties that can be difficult to predict and/or outside of Vivid Seats’ control. Therefore, actual results may differ materially from those contemplated by any such forward-looking statements. Such risks and uncertainties include, but are not limited to: the parties’ ability to consummate the transaction on the terms or timeline proposed, or at all, and to realize the anticipated benefits thereof; the effects of disruption from the transaction making it more difficult to maintain business, financing, and operational relationships; and other factors discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Vivid Seats’ most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as well as in Vivid Seats’ press releases and other filings with the Securities and Exchange Commission. Except as required by applicable law, Vivid Seats undertakes no obligation to update or revise any such forward-looking statements, which speak only as of the date of this press release.

 

Contact:

 

Investors 

Investors@vividseats.com

 

Media 

Press@vividseats.com



2


Exhibit 99.2

 

Cleansing Material

 

· 2027 Guidance

○ Marketplace GOV of $2.3 - 2.7 billion

○ Adjusted EBITDA of $34 - 42 million

○ Unlevered free cash flow of $18 - 30 million

 


1

Filing Exhibits & Attachments

7 documents

Keep reading